comparemela.com

Latest Breaking News On - Karenm anderson - Page 1 : comparemela.com

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month […]

Karenm-anderson
Td-asset-management-inc
Nasdaq
Centessa-pharmaceuticals
Institutional-trading-of-centessa-pharmaceuticals
Insider-activity-at-centessa-pharmaceuticals
Centessa-pharmaceuticals-stock-performance
Analyst-recommendations-for-centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Acuta-capital-partners
Affinity-asset-advisors

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. […]

China
Karenm-anderson
Nasdaq
China-universal-asset-management-co
Centessa-pharmaceuticals-company-profile
Analyst-recommendations-for-centessa-pharmaceuticals
Centessa-pharmaceuticals-trading
Platinum-investment-management-ltd
Centessa-pharmaceuticals
Institutional-trading-of-centessa-pharmaceuticals
Franklin-resources-inc

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 […]

China
Karenm-anderson
China-universal-asset-management-co
Analyst-recommendations-for-centessa-pharmaceuticals
Securities-exchange-commission
Insider-activity-at-centessa-pharmaceuticals
Nasdaq
Affinity-asset-advisors
News-ratings-for-centessa-pharmaceuticals-daily
Acuta-capital-partners
Centessa-pharmaceuticals-trading

Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10.00

Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Karenm-anderson
Harris-rotman
News-ratings-for-centessa-pharmaceuticals-daily
Nasdaq
Securities-exchange-commission
Centessa-pharmaceuticals-stock-down
Centessa-pharmaceuticals
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Rathbones-group
Jump-financial
China-universal-asset-management-co

Centessa Pharmaceuticals (NASDAQ:CNTA) Given Outperform Rating at BMO Capital Markets

BMO Capital Markets reissued their outperform rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Monday morning, Benzinga reports. BMO Capital Markets currently has a $15.00 price objective on the stock. Centessa Pharmaceuticals Stock Performance Shares of CNTA stock opened at $10.37 on Monday. The business has […]

China
Karenm-anderson
Harris-rotman
Susquehanna-international-group
Hedge-funds-weigh-in-on-centessa-pharmaceuticals
Analyst-recommendations-for-centessa-pharmaceuticals
Centessa-pharmaceuticals-stock-performance
Centessa-pharmaceuticals-company-profile
News-ratings-for-centessa-pharmaceuticals-daily
China-universal-asset-management-co
Barclays-plc
Centessa-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.